申请人:Bayer Aktiengesellschaft
公开号:US05204374A1
公开(公告)日:1993-04-20
New cycloalkano[b]dihydroindoles and -indolesulphonamides, substituted by heterocycles, of the formula (I) ##STR1## in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are identical or different and represent hydrogen, nitro, cyano, halogen, trifluoromethyl, carboxyl, hydroxyl or trifluoromethoxy, or represent a group of the formula --S(O).sub.w R.sup.5, in which R.sup.5 denotes alkyl or optionally substituted aryl, w denotes the number 0, 1 or 2, or represents alkoxy or alkoxycarbonyl, or benzyloxy, or represents a group of the formula --NR.sup.6 R.sup.7, in which R.sup.6 and R.sup.7 are identical or different and denote hydrogen, alkyl or acyl or denote aryl, or denote a group of the formula --S(O).sub.w R.sup.5, in which R.sup.5 and w have the abovementioned meaning, represent cycloalkyl or represent optionally substituted alkyl or alkenyl, m represents the number 1, 2, 3 or 4, n represents the number 0, 1 or 2, z represents the number 1, 2, 3 or 4, A represents a bond or the --NH group, X represents an optionally substituted heterocycle, Y represents hydroxyl, alkoxy, phenoxy or a group of the formula --NR.sup.6 R.sup.7, in which R.sup.6 and R.sup.7 have the abovementioned meaning, an isomeric form thereof or salts thereof are useful to treat thromboembolisms, ischaemias, asthma and allergies. Processes of making and chemical intermediates are also disclosed.
新的环烷基[b]二氢吲哚和-吲哚磺酰胺,由杂环取代,其化学式为(I)其中R.sup.1、R.sup.2、R.sup.3和R.sup.4相同或不同,代表氢、硝基、氰基、卤素、三氟甲基、羧基、羟基或三氟甲氧基,或代表一个化学式为--S(O).sub.w R.sup.5的基团,其中R.sup.5表示烷基或可选择取代的芳基,w表示数字0、1或2,或代表烷氧基或烷氧羰基,或苄氧基,或代表一个化学式为--NR.sup.6 R.sup.7的基团,其中R.sup.6和R.sup.7相同或不同,表示氢、烷基或酰基或表示芳基,或表示一个化学式为--S(O).sub.w R.sup.5的基团,其中R.sup.5和w具有上述含义,表示环烷基或表示可选择取代的烷基或烯基,m表示数字1、2、3或4,n表示数字0、1或2,z表示数字1、2、3或4,A表示键或--NH基团,X表示可选择取代的杂环,Y表示羟基、烷氧基、苯氧基或一个化学式为--NR.sup.6 R.sup.7的基团,其中R.sup.6和R.sup.7具有上述含义,其异构体或盐对治疗血栓栓塞、缺血、哮喘和过敏症是有用的。还披露了制备过程和化学中间体。